http://www.nationalboardinstitute.com/members/quitfriday67/activity/ Activity feed for Nikolajsen. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 72b33e9b01f6b68e8241a577d4fc1273 http://www.nationalboardinstitute.com/activity/p/38729/ Wed, 05 Feb 2025 08:05:52 -0800 88 µM)-induced apoptosis and necrosis of DRG neurons. Also, AM significantly ameliorated DOX-induced oxidative stress in DRG neurons. Real-time PCR results showed a significant increase in the expression of TNF-α, IL-1β, iNOS, MMP 3, and MMP 13, and a decrease in the expression of SOX9 following treatment with DOX. Treatment with AM (25 nM) si…[Read more]

]]> 0 1ea16b8aa5b76bd3e60fc81ee53a7d5b http://www.nationalboardinstitute.com/activity/p/36913/ Mon, 03 Feb 2025 08:04:49 -0800 The classification performances based on the area under the receiver operating characteristic curve were 0.83 in GBM and 0.80 in RF. Our study demonstrates the utility of interpretable machine learning in the clinical setting by quantifying the relative importance and cutoff values of predictive variables for Aβ positivity in patients with…[Read more]

]]> 0 6e45509d0d0d8ef6d9c478e8e375b7bb http://www.nationalboardinstitute.com/activity/p/32659/ Tue, 28 Jan 2025 19:23:53 -0800 evolocumab or alirocumab might be effectively used as replacement therapies. Related, most of the available studies preferentially enrolled people with either established CVD or at a high risk already, and evidence in low- to medium-risk settings is minimal. Finally, there is very limited evidence on any potential safety issues of both evolocumab…[Read more]

]]> 0 4c0fe733fe840afaa7cdaa97266758fd http://www.nationalboardinstitute.com/activity/p/32646/ Tue, 28 Jan 2025 19:19:49 -0800 0